The responsiveness of intrinsic subtypes to adjuvant anthracyclines versus nonanthracyclines in NCIC.CTG MA.5 randomized trial.
Volume: 29, Issue: 15_suppl, Pages: 1032 - 1032
Published: May 20, 2011
Abstract
1032 Background: Recent studies have suggested that intrinsic breast cancer subtypes may differ in their responsiveness to specific chemotherapy regimens. We assigned intrinsic subtypes to breast tumors from NCIC.CTG MA.5, a clinical trial that randomized node positive women to CMF (cyclophosphamide-methotrexate-5FU) vs. CMF (cyclophosphamide-epirubicin-5FU), and examined the differential response to adjuvant anthracycline chemotherapy. Methods:...
Paper Details
Title
The responsiveness of intrinsic subtypes to adjuvant anthracyclines versus nonanthracyclines in NCIC.CTG MA.5 randomized trial.
Published Date
May 20, 2011
Journal
Volume
29
Issue
15_suppl
Pages
1032 - 1032
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History